KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Invested Capital (2016 - 2025)

Biogen (BIIB) has 17 years of Invested Capital data on record, last reported at $6.3 billion in Q3 2025.

  • For Q3 2025, Invested Capital rose 37.9% year-over-year to $6.3 billion; the TTM value through Dec 2025 reached $17.6 billion, down 17.17%, while the annual FY2024 figure was $21.3 billion, 1.5% down from the prior year.
  • Invested Capital reached $6.3 billion in Q3 2025 per BIIB's latest filing, down from $23.9 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $23.9 billion in Q2 2025 and bottomed at $4.5 billion in Q3 2024.
  • Average Invested Capital over 5 years is $17.0 billion, with a median of $18.5 billion recorded in 2021.
  • Peak YoY movement for Invested Capital: skyrocketed 131.03% in 2021, then tumbled 63.4% in 2022.
  • A 5-year view of Invested Capital shows it stood at $17.2 billion in 2021, then rose by 14.13% to $19.7 billion in 2022, then increased by 9.75% to $21.6 billion in 2023, then decreased by 1.5% to $21.3 billion in 2024, then plummeted by 70.52% to $6.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $6.3 billion in Q3 2025, $23.9 billion in Q2 2025, and $21.5 billion in Q1 2025.